Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Geographic Atrophy (GA)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01632527
What this trial is testing

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular DegenerationMacular DegenerationAMD
StemCells, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT06990269
What this trial is testing

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc. 240
Testing effectiveness (Phase 2)Looking for participantsNCT07668804
What this trial is testing

Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy

Who this might be right for
Geographic Atrophy Due to Age-Related Macular Degeneration
Theratocular Biotek Co. 31
Not applicableLooking for participantsNCT07556406
What this trial is testing

Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study

Who this might be right for
Age-Related Macular DegenerationGeographic Atrophy
University of California, San Francisco 80
Testing effectiveness (Phase 2)Study completedNCT05811351
What this trial is testing

Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Geographic Atrophy
Janssen Research & Development, LLC 305
Not applicableStudy completedNCT06499571
What this trial is testing

Geographic Atrophy Long-Terms Outcomes Study

Who this might be right for
Geographic Atrophy
Apellis Pharmaceuticals, Inc. 255
Not applicableActive Not RecruitingNCT05797896
What this trial is testing

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyRetinal Disease+4 more
Complement Therapeutics 250
Testing effectiveness (Phase 2)Looking for participantsNCT07392255
What this trial is testing

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics 75
Not applicableStudy completedNCT07424235
What this trial is testing

Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History Cohort

Who this might be right for
Age Related Macular Degeneration (AMD)Age Related Macular DegenerationAMD+3 more
IRCCS Ospedale San Raffaele 60
Not applicableStudy completedNCT07428798
What this trial is testing

Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age Related Macular Degeneration
Marmara University Pendik Training and Research Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00766649
What this trial is testing

Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 11
Large-scale testing (Phase 3)Active Not RecruitingNCT05949593
What this trial is testing

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy

Who this might be right for
Geographic Atrophy
Belite Bio, Inc 429
Large-scale testing (Phase 3)Study completedNCT02686658
What this trial is testing

Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age-Related Macular Degeneration
IVERIC bio, Inc. 286
Not applicableStudy completedNCT02051998
What this trial is testing

Directional Spread in Geographic Atrophy

Who this might be right for
Nonexudative Age-related Macular Degeneration
University Hospital, Bonn 130
Large-scale testing (Phase 3)Not Yet RecruitingNCT07807969
What this trial is testing

An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Annexon, Inc. 605
Testing effectiveness (Phase 2)Ended earlyNCT02467634
What this trial is testing

Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD

Who this might be right for
Age-Related Macular Degeneration
StemCells, Inc. 3
Large-scale testing (Phase 3)Active Not RecruitingNCT06510816
What this trial is testing

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Annexon, Inc. 659
Not applicableUnknownNCT04469140
What this trial is testing

Non Exudative AMD Imaged With SS-OCT- Extension

Who this might be right for
Dry Macular Degeneration
Boston Image Reading Center 450
Testing effectiveness (Phase 2)Ended earlyNCT05893537
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration
Cognition Therapeutics 100
Not applicableLooking for participantsNCT07582042
What this trial is testing

Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).

Who this might be right for
Geographic Atrophy From Age-related Macular Degeneration
University of Utah 50
Next Page